Sidebar - Investor Menu
-
Sarepta Therapeutics 2019 J.P. Morgan Healthcare Conference Presentation
-
Latest Annual Report
( FY 2017 )Latest Annual Report 1.4 MB
Shareholder Tools
Events and Presentations
UPCOMING EVENTS AND PRESENTATIONS
ARCHIVED EVENTS AND PRESENTATIONS
Date | Event Details | Remind Me |
---|---|---|
Summary Toggle
01/7/19 10:30 AM EST |
||
Summary Toggle
11/14/18 12:55 PM EST |
||
Summary Toggle
10/24/18 4:30 PM EDT |
||
Summary Toggle
10/4/18 7:00 AM EDT |
Supporting Materials
Update from WMS 2018 2.4 MB
|
|
Summary Toggle
09/18/18 8:15 AM EDT |
LocationUnion League Club, New York, NY
|
|
Summary Toggle
09/12/18 4:15 PM EDT |
LocationGrand Hyatt New York, New York, NY
|
|
Summary Toggle
08/8/18 4:30 PM EDT |
||
Summary Toggle
07/25/18 5:00 PM EDT |
||
Summary Toggle
06/19/18 7:30 AM EDT |
Supporting Materials
R&D Day 2018 Presentation 12.7 MB
|
|
Summary Toggle
06/6/18 9:00 AM EDT |
The meeting will be held at the Company’s headquarters, 215 First Street, Suite 110B, Cambridge, MA 02142.
|
This section of our website may contain dated or archived information which should not be considered current and may no longer be accurate. For current information, you are encouraged to review our most recent official corporate documents on file with the U.S. Securities and Exchange Commission.
Sarepta's recorded events and presentations contain forward-looking statements that involve risks and uncertainties, including, but not limited to, the results of research and development efforts, the results of preclinical and clinical testing, the effect of regulation by the FDA and other agencies, the impact of competitive products, product development, commercialization and technological difficulties, and other risks detailed in the company's Securities and Exchange Commission filings. Sarepta undertakes no obligation to revise or update the progress of these milestones except to the extent required under applicable federal and state securities laws.
-
Sarepta Therapeutics 2019 J.P. Morgan Healthcare Conference Presentation
-
Latest Annual Report
( FY 2017 )Latest Annual Report 1.4 MB